Remove 2028 Remove Biosimilars Remove International Remove Regulations
article thumbnail

Organon Announces Proposed Senior Notes Offering

The Pharma Data

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Organon Finance 1 LLC plans to offer, subject to market conditions, euro-denominated senior secured notes due 2028, U.S. dollar-denominated senior secured notes due 2028 and U.S.

article thumbnail

Organon Announces Pricing of Senior Notes Offering

The Pharma Data

persons outside the United States in reliance on Regulation S under the Securities Act. In member states of the European Economic Area, this announcement is directed only at persons who are “qualified investors” within the meaning of the Prospectus Regulation.

article thumbnail

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

FDA Law Blog: Biosimilars

CMS will send the final manufacturer invoice for discount liabilities accrued by then on April 30, 2028. CMS also intends to implement a compliance monitoring program through future regulations or guidance. Sunsetting of Coverage Gap Discount Program: The 70% coverage gap discount under the CGDP will continue until December 31, 2024.